✦ LIBER ✦

Expression of interleukin-18 in human ovarian carcinoma and normal ovarian epithelium: Evidence for defective processing in tumor cells

✍ Scribed by Zhao Yuan Wang; Alessia Gaggero; Anna Rubartelli; Ombretta Rosso; Silvia Miotti; Delia Mezzanzanica; Silvana Canevari; Silvano Ferrini

Publisher: John Wiley and Sons
Year: 2002
Tongue: French
Weight: 736 KB
Volume: 98
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.10268

No coin nor oath required. For personal study only.

✦ Synopsis

Interleukin-18 (IL-18) is a proinflammatory monokine structurally related to IL-1beta that stimulates interferon-gamma (IFN-gamma) production. IL-18 is synthesized as an inactive precursor, pro-IL-18, which is cleaved by IL-1beta-converting enzyme (ICE)/caspase-1 in a mature protein. In view of the proposed use of IL-18 in cancer immuno/gene therapy, we have studied the expression of IL-18 in tumor cells. IL-18 mRNA was detected by reverse transcriptase polymerase chain reaction in all human ovarian carcinoma cell lines tested (9/9) and in one-half of tumor cell populations obtained from ovarian carcinoma patients (4/8). ICE mRNA was expressed in a smaller fraction of samples (3/9 cell lines and 3/8 samples from patients). IL-18 protein was also found in 7/13 ovarian carcinoma solid tumors by immunohistochemic analysis. In tumor cell lines we were able to detect abundant intracellular pro-IL-18 (24 kDa) by Western blotting, whereas the mature form of IL-18 was undetectable, irrespective of the presence of ICE mRNA and protein. Only pro-IL-18 was also found in the ovarian carcinoma cell supernatants, which did not display any IL-18 biologic activity in functional assays. Normal cultured ovarian epithelial cells revealed the presence of both IL-18 and ICE mRNA in all samples (5/5) and IL-18 protein was expressed by the thin epithelial cell layer surrounding normal ovary. More importantly, normal ovarian epithelial cells released low but detectable amounts of mature IL-18 in the culture supernatant, which displayed IL-18-like biologic activity in functional assays. These data suggest that mature biologically active IL-18 production is a feature of the normal ovarian surface epithelium lost during neoplastic transformation.

📜 SIMILAR VOLUMES

Gene expression profiles in primary ovar

Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy

✍ Alessandro D. Santin; Fenghuang Zhan; Stefania Bellone; Michela Palmieri; Stefan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 550 KB

## Abstract With the goal of identifying genes with a differential pattern of expression between ovarian serous papillary carcinomas (OSPCs) and normal ovarian (NOVA) epithelium and using this knowledge for the development of novel diagnostic and therapeutic markers for ovarian cancer, we used olig

Modulation of interleukin-18 expression

Modulation of interleukin-18 expression in human colon carcinoma: Consequences for tumor immune surveillance

✍ Franck Pagès; Anne Berger; Berthold Henglein; Bernard Piqueras; Claire Danel; Fr 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 291 KB 👁 2 views

The production in colon cancer of interferon-gamma (IFN-␥), a type-1 T-helper (TH1) cytokine, is considered as a marker of good prognosis. We asked whether interleukin-18 (IL-18), which strongly induces IFN-␥ and regulates Fas ligand (Fas-L)-dependent cytotoxicity, may play a role in colon homeostas

Transforming growth factor β1 (TGF-β1) i

Transforming growth factor β1 (TGF-β1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors

✍ S. Jozan; M. Guerrin; P. Mazars; M. Dutaur; B. Monsarrat; F. Cheutin; R. Bugat; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 957 KB

## Abstract The effects of EGF and TGF‐β1 on the proliferation of 2 ovarian carcinoma cell lines (IGROV1 and OVCCR1) were evaluated. The cell lines were adapted to grow in a restricted serum (0.5%) medium. EGF was required for proliferation of both ovarian cell lines. Low doses of TGF‐β1 inhibited

Different effects of interferons, interl

Different effects of interferons, interleukin-1β and tumor necrosis factor-α in normal (OSE) and malignant human ovarian epithelial cells

✍ Christian Marth; Alain G. Zeimet; Manfred Herold; Christian Brumm; Gudrun Windbi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 573 KB

Ovarian cancer arises mostly from the ovarian surface epithelium. The aim of our study was to compare the effects of cytokines in ovarian surface epithelial (OSE) cells and in ovarian carcinoma cells. Proliferation and expression of surface antigens (CA-I25 and classes I and II antigens of the major

Sensitization by interleukin-lα of carbo

Sensitization by interleukin-lα of carboplatinum anti-tumor activity against human ovarian (NIH:OVCAR-3) carcinoma cells in vitro and in vivo

✍ Zheng Wang; Kang Bo Lee; Eddie Reed; Biranda K. Sinha 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 513 KB

Cytokines are directly cytotoxic to tumor cells in vitro and in vivo, and interleukinla (ILla) potentiates the cytotoxicity of a number of clinically active drugs in several human tumor cells, including carcinomas of the breast and ovary. In this study, we found that ILla potentiated the cytotoxicit

Tumor-derived chemotactic factor(S) from

Tumor-derived chemotactic factor(S) from human ovarian carcinoma: Evidence for a role in the regulation of macrophage content of neoplastic tissues

✍ B. Bottazzi; P. Ghezzi; G. Taraboletti; M. Salmona; N. Colombo; C. Bonazzi; C. M 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 French ⚖ 714 KB

## Abstract Supernatants from freshly disaggregated human ovarian carcinomas maintained __in vitro__ for 24 hr, from primary ovarian carcinoma cultures (4–6 days in culture) and from established ovarian cancer cell lines were examined for chemotactic activity on blood monocytes in blind‐well chemot